デフォルト表紙
市場調査レポート
商品コード
1447940

医療費償還の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2023年~2030年)- 請求額別、支払者別、サービスプロバイダー別、地域別、企業別

Healthcare Reimbursement Market - Global Healthcare Reimbursement Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Claim Coverage, By Payer Coverage, By Service Provider Coverage, By Geographic Coverage and By Company)

出版日: | 発行: Fairfield Market Research | ページ情報: 英文 216 Pages | 納期: 2~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
医療費償還の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2023年~2030年)- 請求額別、支払者別、サービスプロバイダー別、地域別、企業別
出版日: 2024年02月22日
発行: Fairfield Market Research
ページ情報: 英文 216 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 目次
概要

医療費償還の市場規模は飛躍的な成長を遂げようとしています。2022年には112億米ドルとなりましたが、2023年から2030年にかけての年間平均成長率(CAGR)は18.2%と驚異的な伸びを示し、2030年には361億米ドルに達すると予測されています。

この前例のない成長軌道を支えている主な要因の1つは、ヘルスケア用途の人気が高まっていることです。電子カルテ(EHR)、遠隔医療、データ分析などの技術革新は、効率性と正確性を高めることで償還プロセスに革命をもたらしています。これらの進歩は請求処理を合理化し、エラーを減らし、透明性のある請求業務を保証することで、革新的な償還ソリューションの需要を促進しています。

さらに、医療費の上昇と慢性疾患の有病率の増加が市場拡大に大きく寄与しています。医療費が増加の一途をたどる中、効率的で透明性の高い償還プロセスに対する需要が高まっています。このため、革新的な償還モデルとバリューベースのケア戦略を開発し、慢性疾患の患者に対するタイムリーで適切なケアを確保しながら、コストを効果的に管理する必要があります。

当レポートでは、世界の医療費償還市場について調査し、市場の概要とともに、請求額別、支払者別、サービスプロバイダー別、地域別、企業別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の医療費償還市場の見通し、2018年~2030年

  • 世界の医療費償還市場の見通し、請求額別(10億米ドル)、2018年~2030年
  • 世界の医療費償還市場の見通し、支払者別、金額(10億米ドル)、2018年~2030年
  • 世界の医療費償還市場の見通し、サービスプロバイダー別、金額(10億米ドル)、2018年~2030年
  • 世界の医療費償還市場の見通し、地域別、金額(10億米ドル)、2018年~2030年

第4章 北米の医療費償還市場の見通し、2018年~2030年

第5章 欧州の医療費償還市場の見通し、2018年~2030年

第6章 アジア太平洋の医療費償還市場の見通し、2018年~2030年

第7章 ラテンアメリカの医療費償還市場の見通し、2018年~2030年

第8章 中東・アフリカの医療費償還市場の見通し、2018年~2030年

第9章 競合情勢

  • サービスプロバイダーと請求額ヒートマップ
  • 企業市場シェア分析、2022年
  • 競合ダッシュボード
  • 企業プロファイル
    • UnitedHealth Group
    • Anthem, Inc.
    • Cigna
    • Humana Inc.
    • Blue Cross Blue Shield Association
    • Centene Corporation
    • Molina Healthcare
    • Kaiser Permanente
    • CVS Health
    • Tenet Healthcare
    • HCA Healthcare
    • Magellan Health
    • Universal American
    • Gateway Health The Joint Commission

第10章 付録

目次

Healthcare reimbursement market is set to experience exponential growth, according to the latest report by [Your Company/Institution]. With an estimated worth of US$11.2 billion in 2022, the market is forecasted to soar to US$36.1 billion by 2030, reflecting a staggering Compound Annual Growth Rate (CAGR) of 18.2% during the period of 2023 to 2030.

Fueling Factors Behind Growth

Advancements in Healthcare Technology

One of the primary drivers behind this unprecedented growth trajectory is the increasing popularity of healthcare applications. Technological innovations, including electronic health records (EHRs), telemedicine, and data analytics, are revolutionizing reimbursement processes by enhancing efficiency and accuracy. These advancements streamline claims processing, reduce errors, and ensure transparent billing practices, thereby driving the demand for innovative reimbursement solutions.

Rising Healthcare Expenditure and Chronic Disease Prevalence

Moreover, rising healthcare costs coupled with the increasing prevalence of chronic diseases are significant contributors to market expansion. As healthcare expenses continue to escalate, there is a growing demand for efficient and transparent reimbursement processes. This necessitates the development of innovative reimbursement models and value-based care strategies to manage costs effectively while ensuring timely and appropriate care for patients with chronic conditions.

Key Trends and Opportunities

Telehealth Integration

Telehealth integration emerges as a pivotal trend in the healthcare reimbursement market, facilitating accurate billing and payment processes for virtual healthcare services. By automating claims submission and supporting transparent billing practices, telehealth integration ensures efficient reimbursement in the evolving healthcare landscape.

Electronic Health Records (EHRs) and Robotic Process Automation (RPA)

Integration of EHR systems and RPA technology further optimizes reimbursement workflows by enhancing data accuracy and automating repetitive tasks. These innovations reduce administrative burdens and accelerate reimbursement processes, ultimately driving market growth.

Challenges and Opportunities

Complex Regulations and Administrative Burden

However, the market faces challenges due to complex regulations and administrative burdens. Navigating intricate compliance requirements and evolving regulatory landscapes requires continuous training and technology updates. Streamlining administrative tasks through automation and improved technology presents an opportunity to alleviate this challenge and enhance reimbursement efficiency.

Regional Dynamics

North America's Leadership and Asia Pacific's Growth Prospects

North America leads the global healthcare reimbursement market, driven by its advanced healthcare infrastructure and extensive insurance coverage. In contrast, Asia Pacific witnesses rapid growth fueled by increasing healthcare investments and expanding insurance coverage. The adoption of advanced technologies and evolving reimbursement policies align with the region's modernization efforts, making it a dynamic and rapidly expanding market.

Competitive Landscape

Leaders in the Global Healthcare Reimbursement Market

The market is dominated by key players such as Magellan Health, UnitedHealth Group, Anthem, Inc., Cigna, and Humana Inc. These companies are introducing new products and enhancing distribution channels to consolidate their global presence. More consolidation is expected in the coming years, further shaping the competitive landscape of the healthcare reimbursement market.

Global Healthcare Reimbursement Market is Segmented as Below:

By Claim:

  • Fully Paid
  • Underpaid

By Payer:

  • Private Payers
  • Public Payers

By Service Provider:

  • Physician Office
  • Hospitals
  • Diagnostic Laboratories
  • Others

By Geographic Coverage:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Egypt
    • Nigeria
    • Rest of the Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Healthcare Reimbursement Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 3.1. Global Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Fully Paid
      • 3.1.1.2. Underpaid
  • 3.2. Global Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Private Payers
      • 3.2.1.2. Public Payers
  • 3.3. Global Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Physician Office
      • 3.3.1.2. Hospitals
      • 3.3.1.3. Diagnostic Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Healthcare Reimbursement Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 4.1. North America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Fully Paid
      • 4.1.1.2. Underpaid
  • 4.2. North America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Private Payers
      • 4.2.1.2. Public Payers
  • 4.3. North America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Physician Office
      • 4.3.1.2. Hospitals
      • 4.3.1.3. Diagnostic Laboratories
      • 4.3.1.4. Others
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 4.4.1.2. U.S. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 4.4.1.3. U.S. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 4.4.1.4. U.S. Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
      • 4.4.1.5. Canada Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 4.4.1.6. Canada Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 4.4.1.7. Canada Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 4.4.1.8. Canada Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 5.1. Europe Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Fully Paid
      • 5.1.1.2. Underpaid
  • 5.2. Europe Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Private Payers
      • 5.2.1.2. Public Payers
  • 5.3. Europe Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Physician Office
      • 5.3.1.2. Hospitals
      • 5.3.1.3. Diagnostic Laboratories
      • 5.3.1.4. Others
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.2. Germany Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.3. Germany Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.4. U.K. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.5. U.K. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.6. U.K. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.7. France Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.8. France Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.9. France Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.10. Italy Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.11. Italy Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.12. Italy Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.13. Turkey Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.14. Turkey Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.15. Turkey Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.16. Russia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.17. Russia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.18. Russia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.19. Rest of Europe Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.20. Rest of Europe Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.21. Rest of Europe Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Fully Paid
      • 6.1.1.2. Underpaid
  • 6.2. Asia Pacific Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Private Payers
      • 6.2.1.2. Public Payers
  • 6.3. Asia Pacific Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Physician Office
      • 6.3.1.2. Hospitals
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.2. China Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.3. China Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.4. Japan Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.5. Japan Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.6. Japan Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.7. South Korea Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.8. South Korea Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.9. South Korea Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.10. India Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.11. India Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.12. India Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.13. Southeast Asia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.14. Southeast Asia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.15. Southeast Asia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.16. Rest of Asia Pacific Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.17. Rest of Asia Pacific Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.18. Rest of Asia Pacific Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 7.1. Latin America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Fully Paid
      • 7.1.1.2. Underpaid
  • 7.2. Latin America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Private Payers
      • 7.2.1.2. Public Payers
  • 7.3. Latin America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Physician Office
      • 7.3.1.2. Hospitals
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.2. Brazil Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.3. Brazil Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.4. Mexico Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.5. Mexico Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.6. Mexico Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.7. Argentina Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.8. Argentina Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.9. Argentina Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.10. Rest of Latin America Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.11. Rest of Latin America Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.12. Rest of Latin America Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Fully Paid
      • 8.1.1.2. Underpaid
  • 8.2. Middle East & Africa Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Private Payers
      • 8.2.1.2. Public Payers
  • 8.3. Middle East & Africa Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Physician Office
      • 8.3.1.2. Hospitals
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.2. GCC Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.3. GCC Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.4. South Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.5. South Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.6. South Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.7. Egypt Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.8. Egypt Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.9. Egypt Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.10. Nigeria Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.11. Nigeria Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.12. Nigeria Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.13. Rest of Middle East & Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.14. Rest of Middle East & Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.15. Rest of Middle East & Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Service Provider vs Claim Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. UnitedHealth Group
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Anthem, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Cigna
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Humana Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Blue Cross Blue Shield Association
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Centene Corporation
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Molina Healthcare
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Kaiser Permanente
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. CVS Health
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Tenet Healthcare
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. HCA Healthcare
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Magellan Health
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Universal American
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Gateway Health
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. The Joint Commission
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations